Guideline: LNDTA Guidelines (Lithuania): Difference between revisions
From Beacon
m (Update categories.) |
m (Update categories.) |
||
| Line 22: | Line 22: | ||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | <span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | ||
<span style="display:none">isPracticeGuideline</span> | <span style="display:none">isPracticeGuideline</span> | ||
<span style="display:none">hasCancerType::C00-D48: All neoplasms</span> | |||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
Revision as of 11:22, 6 December 2025
Go back to Lithuania page
Sponsor, manager or home institution: Lietuvos nefrologijos, dializės ir transplantacijos asociacijos.
Primary purpose: To prepare recommendations on how to optimize the diagnosis and treatment of kidney diseases.
Type of information: Recommendations, diagnosis, monitoring, evaluation and treatments of kidney diseases. Click here to learn more.
Cancer areas of interest: C64-C68: Urinary system cancers. Click here to learn more.
Access to information: Click here to access.
